Search Results 1021-1030 of 16744 for Efficacy

  1. A Study to Evaluate the Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in subjects with moderately and ...

  2. Dermatitis Clinical Trials - Mayo Clinic Research

    This study is a 2-part (parts A and B) phase 2/3 study to evaluate the safety, pharmacokinetics (PK) and efficacy of dupilumab in patients 6 months to less ...

  3. Seizures Clinical Trials - Mayo Clinic Research

    Additionally, this study proposes to determine efficacy of combination therapy of Cosyntropin Injectable Suspension, 1 mg/mL and vigabatrin to monotherapy ...

  4. The emerging option of upper airway stimulation therapy - Mayo Clinic

    Maintenance of upper airway stimulation therapy efficacy at three and five years in the STAR cohort has subsequently been reported. Treatment at Mayo Clinic.

  5. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  6. Study Evaluating Intepirdine (RVT-101) In Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study - Mayo Clinic

    This study seeks to evaluate the efficacy and safety of intepirdine (RVT-101) in patients with dementia with Lewy bodies. Participation eligibility.

  7. Hematology - Clinical trials

    The aim of this study is to study the efficacy and safety of our short and long one-day protocols for TMP-SMX graded administration in hematologic ...

  8. Study Of SIM0500 Alone In Participants With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    This is an open-label, multicenter phase 1 clinical trial to evaluate the safety and tolerability, efficacy, and pharmacokinetics of SIM0500 in adult ...

  9. A Study to Analyze SAR442168 in Participants with Nonrelapsing Secondary Progressive Multiple Sclerosis - Mayo Clinic

    This study aims to determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMS and on clinical endpoints, MRI ...

  10. Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian) - Mayo Clinic

    About this study. This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of combining durvalumab ...